Lovenox and Pentasa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Pentasa (mesalamine). Common drug interactions include areflexia among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Lovenox and Pentasa. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.
What is Lovenox?
Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.
What is Pentasa?
Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. eHealthMe is studying from 23,325 Pentasa users. Check the latest studies of Pentasa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
67 people who take Lovenox and Pentasa together, and have interactions are studied.

What are the common drug interactions of Lovenox and Pentasa, by gender? *:
female:
- Areflexia (absence of a reflex)
- Arthropathy
- Ascites (accumulation of fluid in the abdominal cavity)
- Ataxia (loss of full control of bodily movements)
- Atrophy (wasting away of a part of the body)
- Back pain
- Balance disorder
- Biliary cirrhosis (biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver)
- Blood corticotrophin decreased
- Blood cortisol decreased
male:
- Abdominal pain
- Hospitalisation
- Nephropathy (damage to or disease of a kidney)
- Psoas abscess (collection of pus in the iliopsoas muscle compartment)
- Rectal haemorrhage (bleeding from anus)
- Renal atrophy (wasting of kidney)
- Renal impairment (severely reduced kidney function)
- Urinary tract infection
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Diarrhoea
What are the common drug interactions of Lovenox and Pentasa, by age (0-1 to 60+)? *:
0-1:
- Bradycardia (abnormally slow heart action)
- Dysmorphism (difference of body structure that is suggestive of a congenital disorder)
- Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
- Hypotonia neonatal (low muscle tone in neonatal)
- Talipes
2-9:
n/a
10-19:
- Anaemia (lack of blood)
- Eyelid oedema (eyelids are swollen and contain excessive fluid)
- Face oedema (swelling of face)
- Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
- Myocarditis (inflammation of heart muscle myocardium)
- Renal failure (kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Thrombosis (formation of a blood clot inside a blood vessel)
20-29:
- Abdominal pain
- Hospitalisation
- Inflammation
- Migraine with aura (headache with vision weakness)
- Depression
- Rectal haemorrhage (bleeding from anus)
- Drug resistance (reduction in effectiveness of a drug)
- Anaemia (lack of blood)
- Intestinal obstruction
- Postoperative ileus
30-39:
- Antepartum haemorrhage (bleeding from the vagina during pregnancy from the 24th week)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Fall
- Premature separation of placenta
- Skeletal injury (bone and supporting muscle injury)
- Upper respiratory tract infection
- Viral infection
- Drug exposure during pregnancy
40-49:
- Hypoxia (low oxygen in tissues)
- Lung disorder (lung disease)
- Sputum purulent
- Hepatocellular injury (liver injury)
- Lung infection pseudomonal (bacterial infection of lung by pseudomonas aeruginosa)
- Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
- Death
- Drug intolerance (drug sensitivity)
- Infusion related reaction
- Polyarthritis (arthritis which involves 5 or more joints simultaneously)
50-59:
- Escherichia infection (bacterial infection by escherichia coli)
- Hyperoxaluria (excessive urinary excretion of oxalate)
- Nausea (feeling of having an urge to vomit)
- Nephrolithiasis (calculi in the kidneys)
- Nephropathy (damage to or disease of a kidney)
- Psoas abscess (collection of pus in the iliopsoas muscle compartment)
- Renal atrophy (wasting of kidney)
- Renal impairment (severely reduced kidney function)
- Urinary tract infection
- Vomiting
60+:
- Thrombocytopenia (decrease of platelets in blood)
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Vomiting
- Hepatitis (inflammation of the liver)
- Hyperbilirubinaemia (excess of bilirubin in the blood)
- Abdominal discomfort
- Abdominal pain
- Abdominal pain upper
- Activities of daily living impaired
- Acute myocardial infarction (acute heart attack)
What are the existing conditions these people have? *
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 14.93%
- Colitis (inflammation of colon): 9 people, 13.43%
- Pain: 6 people, 8.96%
- Asthma: 6 people, 8.96%
- Immune System Disorder: 5 people, 7.46%
- Depression: 4 people, 5.97%
- Angioedema (rapid swelling of the dermis): 4 people, 5.97%
* Approximation only. Some reports may have incomplete information.
Do you take Lovenox and Pentasa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lovenox and Pentasa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lovenox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pentasa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lovenox and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pentasa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on enoxaparin sodium and mesalamine (the active ingredients of Lovenox and Pentasa, respectively), and Lovenox and Pentasa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Ibuprofen and Orkambi - now
- Entyvio and Gastrointestinal Disorder for Women aged 30-39 - a second ago
- Zyloprim and Ultram drug interactions for men aged 60+ - 2 seconds ago
- Ceftazidime and Diarrhoea Aggravated for Men aged 50-59 - 3 seconds ago
- Ceftazidime and Diarrhea Aggravated for Men aged 50-59 - 3 seconds ago
- Bactrim and Vitamin B12 drug interactions for men aged 60+ - 3 seconds ago
- Drug interactions of Prezcobix and Norvir - 3 seconds ago
- Zyloprim and Ultram drug interactions for men aged 50-59 - 4 seconds ago
- Rashes and drugs of ingredients of peppermint - 4 seconds ago
- Drug interactions of Glipizide and Celebrex - 6 seconds ago